Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF STRATEGY OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,465 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 951 · Balance 29,273 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,179 · Balance 30,452 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 2,790 · Balance 33,242 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 1,777 · Balance 31,465 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,706 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 951 · Balance 5,706 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,359 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,179 · Balance 2,359 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,742 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 2,790 · Balance 16,742 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,777 | $7.16 | $12,730.43 |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,465 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · derivative · entry 7 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,742 Underlying: Common Stock · 2,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · derivative · entry 6 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,359 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 951 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · derivative · entry 5 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,706 Underlying: Common Stock · 951 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 951 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000188 · wk-form4_1725480714.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,790 | $11.16 | $19,971.03 |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,322 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · derivative · entry 7 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,532 Underlying: Common Stock · 2,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · derivative · entry 6 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,538 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 951 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · derivative · entry 5 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,657 Underlying: Common Stock · 951 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 951 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 17, 2024 Filed May 17, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $12.83 | $12,830.00 |
DisclosureSEC source: 0001477449-24-000111 · wk-form4_1715976314.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,192 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| April 17, 2024 Filed Apr 17, 2024 20:54 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $13.21 | $13,210.00 |
DisclosureSEC source: 0001477449-24-000096 · wk-form4_1713387281.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,192 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 40,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000073 · wk-form4_1710965472.xml · derivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,800 Underlying: Common Stock · 40,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 18, 2024 Filed Mar 18, 2024 20:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $15.18 | $15,180.00 |
DisclosureSEC source: 0001477449-24-000053 · wk-form4_1710795388.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,192 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,780 | $14.52 | $98,418.48 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 7 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,192 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 956 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 14 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F12 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 11,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 13 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,322 Underlying: Common Stock · 11,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 12 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,717 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 722 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 11 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 364 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 10 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F8 · derivative.expiration_date: On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 9 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,608 Underlying: Common Stock · 3,803 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 11,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · derivative · entry 8 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,411 Underlying: Common Stock · 11,411 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 6 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 11,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 5 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 4 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,803 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000040 · wk-form4_1709672868.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 22:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $20.64 | $20,640.00 |
DisclosureSEC source: 0001477449-24-000019 · wk-form4_1708466555.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,788 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $19.46 | $19,460.00 |
DisclosureSEC source: 0001477449-24-000004 · wk-form4_1705611951.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,788 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $20.36 | $20,360.00 |
DisclosureSEC source: 0001477449-23-000110 · wk-form4_1703019904.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,788 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 427 | $18.90 | $8,071.15 |
DisclosureSEC source: 0001477449-23-000103 · wk-form4_1701810404.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,788 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000103 · wk-form4_1701810404.xml · derivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,896 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000103 · wk-form4_1701810404.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 21:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $17.07 | $17,070.00 |
DisclosureSEC source: 0001477449-23-000082 · wk-form4_1700514323.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,036 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| October 17, 2023 Filed Oct 18, 2023 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $18.74 | $18,740.00 |
DisclosureSEC source: 0001477449-23-000058 · wk-form4_1697659630.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,036 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $21.00 | $21,000.00 |
DisclosureSEC source: 0001477449-23-000047 · wk-form4_1695153915.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,036 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 426 | $22.89 | $9,752.84 |
DisclosureSEC source: 0001477449-23-000042 · wk-form4_1694031388.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,036 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000042 · wk-form4_1694031388.xml · derivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,075 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000042 · wk-form4_1694031388.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $22.81 | $22,810.00 |
DisclosureSEC source: 0001477449-23-000024 · wk-form4_1692389210.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,283 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $24.66 | $24,660.00 |
DisclosureSEC source: 0001477449-23-000001 · wk-form4_1689711469.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,283 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,000 | $24.61 | $24,610.00 |
DisclosureSEC source: 0001415889-23-010089 · form4-06212023_080612.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,283 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 416 | $24.38 | $10,142.50 |
DisclosureSEC source: 0001415889-23-009201 · form4-06052023_080628.xml · nonDerivative · entry 2 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,283 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009201 · form4-06052023_080628.xml · derivative · entry 3 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,254 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009201 · form4-06052023_080628.xml · nonDerivative · entry 1 Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.